Sharon Yavrom

Company: IMUGENE

Job title: Executive Director, Clinical Science

Seminars:

Overview of CF33 Vaccinia Oncolytic Virus Platform 9:30 am

Scientific review of the CF33 OV platform Clinical development overview of CF33, checkvacc (CF33-PDL1), and onCARlytic (CF33-CD19) Future development of the OV platformRead more

day: Day One